A 52-year-old man from Delhi presents with severe COVID-19 pneumonia requiring ICU admission. His serum IL-6 is markedly elevated at 450 pg/mL (normal <7). Regarding SARS-CoV-2 pathogenesis and the cytokine storm, all of the following statements are correct EXCEPT:

Explanation

## SARS-CoV-2 Pathogenesis and Cytokine Storm Mechanisms **Key Point:** Severe COVID-19 involves a dysregulated innate immune response characterized by cytokine storm. Understanding which cells produce IL-6 and the viral antagonism mechanisms is high-yield. ### Viral Immune Evasion Mechanisms | Viral Protein | Immune Target | Mechanism | |---------------|---------------|----------| | **N protein** | STAT1 pathway | Blocks phosphorylation and nuclear translocation; antagonizes IFN signaling | | **ORF6 protein** | Nuclear import | Inhibits STAT1/STAT2 nuclear entry | | **ORF3b protein** | IRF3 pathway | Suppresses interferon-β production | | **M protein** | NF-κB pathway | Inhibits pro-inflammatory signaling | ### IL-6 Production in COVID-19 **High-Yield:** IL-6 in severe COVID-19 is primarily produced by **immune cells** (macrophages, monocytes, dendritic cells) and activated T cells, NOT by infected epithelial cells. This is a critical distinction: 1. **Infected epithelial cells** produce type I interferons and chemokines (IL-8, MCP-1) 2. **Immune cells** produce IL-6, TNF-α, IL-1β in response to viral PAMPs and DAMPs 3. **Elevated IL-6** correlates with: - Increased disease severity - Worse outcomes - Requirement for ICU admission - Mortality risk **Warning:** The statement "IL-6 is primarily produced by infected epithelial cells" is FALSE. IL-6 is a secondary mediator produced by activated macrophages and immune cells responding to viral infection, not by the infected epithelial cells themselves. ### Correct Pathogenic Mechanisms ```mermaid flowchart TD A[SARS-CoV-2 infection]:::outcome --> B[Viral proteins antagonize IFN signaling]:::action B --> C[Reduced IFN-β early in infection]:::outcome A --> D[Viral PAMPs recognized by TLRs]:::action D --> E[Macrophage/monocyte activation]:::action E --> F[IL-6, TNF-α, IL-1β production]:::outcome F --> G[Cytokine storm]:::urgent G --> H[Severe pneumonia, ARDS]:::urgent ``` **Clinical Pearl:** The paradox of COVID-19 is that early viral antagonism of interferon responses (mediated by N, ORF6, ORF3b proteins) allows unchecked viral replication, which then triggers massive secondary immune activation and cytokine storm. This explains why interferon-based therapies may be beneficial early but harmful late in disease. [cite:Harrison 21e Ch 197]